STURDECA Trademark

Trademark Overview

On Tuesday, June 28, 2011, a trademark application was filed for STURDECA with the United States Patent and Trademark Office. The USPTO has given the STURDECA trademark a serial number of 85358714. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 18, 2014. This trademark is owned by Gilead Sciences Limited. The STURDECA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely antivirals; pharmaceuticals for the treatment of infectious diseases and disorders and HIV infection
sturdeca

General Information

Serial Number85358714
Word MarkSTURDECA
Filing DateTuesday, June 28, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 18, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 22, 2011

Trademark Statements

Goods and ServicesPharmaceuticals, namely antivirals; pharmaceuticals for the treatment of infectious diseases and disorders and HIV infection

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 6, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGILEAD SCIENCES IRELAND UC
Party Type21 - New Owner After Publication
Legal Entity Type99 - Other
AddressCARRIGTOHILL, CO. CORK
IE
Party NameGilead Sciences Limited
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressCarrigtohill, Co. Cork
IE
Party NameGilead Sciences Limited
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressCarrigtohill, Co. Cork
IE

Trademark Events

Event DateEvent Description
Wednesday, November 12, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, August 18, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 18, 2014ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 12, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 11, 2013EXTENSION 4 GRANTED
Tuesday, November 26, 2013EXTENSION 4 FILED
Tuesday, November 26, 2013TEAS EXTENSION RECEIVED
Wednesday, May 15, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 14, 2013EXTENSION 3 GRANTED
Thursday, May 9, 2013EXTENSION 3 FILED
Thursday, May 9, 2013TEAS EXTENSION RECEIVED
Thursday, November 22, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 21, 2012EXTENSION 2 GRANTED
Monday, November 19, 2012EXTENSION 2 FILED
Wednesday, November 21, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 19, 2012TEAS EXTENSION RECEIVED
Wednesday, June 13, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 11, 2012EXTENSION 1 GRANTED
Monday, June 11, 2012EXTENSION 1 FILED
Monday, June 11, 2012TEAS EXTENSION RECEIVED
Tuesday, January 17, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 22, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 22, 2011PUBLISHED FOR OPPOSITION
Wednesday, November 2, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 25, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 13, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 13, 2011ASSIGNED TO EXAMINER
Wednesday, October 5, 2011TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Wednesday, October 5, 2011TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, July 6, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 1, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

sturdeca pharmaceuticals disorders infection diseases treatment namely antivirals infectious